News and Comments

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

INNOVIVA (INVA) Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) NEKTAR (NKTR)) REGULUS (RGLS) Ziofpharm (ZIOP) Spike Therapeutics (ONCE) Sequenom (SQNM) Tysabri GUARDIAN HEALTH Sarepta (SRPT) Alder Biopharmaceuticals (ALDR) Theravance (THRX) PTC Therapeutics (PTCT) AstraZeneca (AZN) Agenus (AGEN Micromet (MITI) AGOS (ARGS) Ionis (IONS) Genentech Inovio (INO) Biocryst (BCRX) VANDA (VNDA) Pluristem (PSTI) Xoma (XOMA) CompuGen (CGEN) Trastuzumab-DM1 ImmunoGen (IMGN) Vitae Pharmaceuticals (VTAE) RenenxBio (RGNX) Jazz Pharmaceuticals (JAZZ) Regeneron (REGN) Alnylam (ALNY) ACADIA (ACAD) JUNO (JUNO) Galena (GALE) Mirati Therapeutics (MRTX) Aimmune Therapeutics (AIMT) Telaprevir Human Longevity (HLI) ABBVIE (ABBV) NANTKWEST (NK) Ariad (ARIA) Illumina (ILMN) ARCA (ABIO) Sanofi-Aventis (SAN) Endometrial Cancer NOVOCURE (NVCR) Idenix (IDIX) Benlysta (belimumab) Rapamune Agenus (AGEN) Ridaforolimus C4 Therapeutics KERYX (KERX) Dendreon (DNDN) Intrexon (XON) Prosensa (RNA) SYNTA (SNTA) Roche (ROCHE) Vertex (VRTX) GlaxoSmithKline (GSK) TOKAI (TKAOI) Velcade (bortezomib) AERIE PHARMACEUTICALS Global Cell Therapeutics (GBT) Sanofi (SNY) Anadys (ANDS) Herceptin Incyte (INCY) Prolor Biotech (PBTH) Anacor (ANAC) ISIS (ISIS) Exelixis (EXEL) Editas (EDIT) Intercept (ICPT) Merck (MRK) Theravance Bio Pharma (TBPH) Human Genome Sciences (HGSI) Cytokinetics (CYTK) ZALTRAP™ Dynavax (DVAX) SERES THERAPEUTICS (MCRB) Multiple Myeloma Biogen Idec (BIIB) Sanofi (SNA) Amgen (AMGN) ADVENTRIX (ANX) IDERA (IDRA) Sangamo (SGMO) OSI (OSIP) HALOZYME (HALO) Bristol-Myers Squibb (BMY) Array Pharmaceuticals (ARRY) Valeant Pharmaceuticals International (VRX) Gilead (GILD) Elan (ELN) Revlimid (lenolidamide) KITE (KITE) MODERNA ARGOS (ARGS) Roche (RHHBY) Onyx (ONXX) Zerenex Auspex (ASPX) BIOMARIN (BMRN) Intermune (ITMN) galapagos (GLPG) Seattle Genetics (SGEN)